Finance

Lists
Why is OKUR down 3,10%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
2,34 $
-3,10%
(-0,075) 1D
2,34 $
0,00% (0,00)
After hours
Closed: 13 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
2,40 $
High
2,40 $
Low
2,31 $
Mkt. cap
94,96 млн
Avg. vol.
319,25 м.
Volume
232,55 м.
52-wk high
5,38 $
52-wk low
2,13 $
EPS
-3,50 $
Beta
0,12
Shares outstanding
40,50 млн
No. of employees
45
Open
2,40 $
High
2,40 $
Low
2,31 $
Mkt. cap
94,96 млн
Avg. vol.
319,25 м.
Volume
232,55 м.
52-wk high
5,38 $
52-wk low
2,13 $
EPS
-3,50 $
Beta
0,12
Shares outstanding
40,50 млн
No. of employees
45
News stories
From web sources and news partners
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
HeadquartersБоулдер, Колорадо, Америка Құрама Штаттары
Sector-
Websiteonkuretherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current 2,34 $
21,00 $ (+795,52%)
Average
17,00 $ (+624,95%)
Lowest
14,00 $ (+497,01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
14,00 $
+497%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
14,00 $
+497%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
16,00 $
+582,3%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
21,00 $
+795,5%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
17,00 $
+624,9%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,92 млн
10,72 млн
11,71 млн
12,61 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 млн
3,40 млн
3,91 млн
4,29 млн
Operating expense
15,50 млн
14,12 млн
15,62 млн
16,90 млн
Total operating expenses
15,50 млн
14,12 млн
15,62 млн
16,90 млн
Operating income
-15,50 млн
-14,12 млн
-15,62 млн
-16,90 млн
Other non operating income
-
-
-
-
EBT including unusual items
-14,70 млн
-13,50 млн
-15,16 млн
-15,35 млн
EBT excluding unusual items
-14,70 млн
-13,50 млн
-15,16 млн
-15,35 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,70 млн
-13,50 млн
-15,16 млн
-15,35 млн
Net profit margin
-
-
-
-
Earnings per share
-1,09
-0,99
-1,11
-0,31
Interest and investment income
804,00 м.
628,00 м.
458,00 м.
1,55 млн
Interest expense
-2,00 мың
-6,00 мың
-
-
Net interest expenses
802,00 м.
622,00 м.
458,00 м.
1,55 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,39 млн
-14,02 млн
-15,51 млн
-16,81 млн
Gain or loss from assets sale
2,00 мың
4,00 мың
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары